Related Experiment Video

Updated: May 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Neuroimmune mechanisms of depression in heart failure

Jessica A Jiménez1, Paul J Mills

  • 1Department of Psychiatry, University of California at San Diego, San Diego, CA, USA.

Methods in Molecular Biology (Clifton, N.J.)
|August 31, 2012
PubMed

Insights

Heart failure patients often experience depression, leading to poorer health outcomes. This study explores the psychoneuroimmunologic mechanisms linking heart failure and depression, focusing on neurohormonal and cytokine pathways.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychoneuroimmunology

Background:

  • Heart failure (HF) presents significant public health challenges with high hospitalization and mortality rates.
  • Co-occurrence of depression in HF patients is prevalent and associated with adverse clinical outcomes.
  • Understanding the link between HF and depression is crucial for improving patient prognosis.

Purpose of the Study:

  • To introduce the study of depression in heart failure patients.
  • To explore the psychoneuroimmunologic mechanisms underlying the comorbidity of HF and depression.
  • To elucidate the roles of neurohormonal and cytokine activation in this relationship.

Main Methods:

  • Literature review and synthesis of psychoneuroimmunologic principles.
  • Examination of neurohormonal pathways implicated in HF and depression.
  • Analysis of cytokine activation as a potential mediator.

Main Results:

  • Depression is a significant comorbidity in heart failure.
  • Psychoneuroimmunologic pathways, including neurohormonal and cytokine activation, are implicated in linking HF and depression.
  • These mechanisms may explain the poorer outcomes observed in depressed HF patients.

Conclusions:

  • Depression negatively impacts heart failure prognosis.
  • Psychoneuroimmunology offers a framework for understanding the biological links between HF and depression.
  • Further research into these mechanisms can inform targeted therapeutic interventions.

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...